The PSA test has been the gold-standard treatment for detecting prostate cancer, but key shortcomings have prevented national ...

Biopsies are recommended for new lesions and post-treatment evaluation, with PSMA PET scans used selectively. Here are expert answers to common questions about a prostate cancer experience, ...

Using AI to Measure Prostate Cancer Lesions Could Aid Diagnosis and Treatment Oct. 29, 2024 — Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are ...

A recent study published in the Prostate Cancer and Prostatic Diseases evaluated focal therapy with high-intensity focused ...

Nov. 14, 2024 — Researchers have developed a three-dimensional mathematical model of prostate cancer. The model depicts various processes, including tumour growth, genetic evolution and tumour cell ...

PSMA PET has been increasingly used in high-risk primary, recurrent, and metastatic prostate cancer patients. With its increasing use, we encounter several dural-based intracranial lesions such as ...

lesion characteristics, history of prior biopsies, and AI evaluations, focusing mainly on the detection of clinically significant prostate cancer (csPCa) (International Society of Urological Pathology ...

“Prostate cancer patients with life expectancies of less than 5 or 10 years were being subjected to treatments that can take up to a decade to significantly improve their chances of surviving cancer, ...

Most clinicians do not use ultrasound to detect prostate cancer or to target suspicious lesions for biopsy owing to the inaccuracies of identifying the tumor with standard ultrasound techniques.

Deep Bio, a leader in artificial intelligence for digital pathology, announced a collaboration to integrate its prostate ...

Brain metastases from prostate cancer (PC) seem to be more frequent ... and not used in the case of secondary lesions involving the leptomeningeal and pachymeningeal (dural) compartments; dural ...